A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation

被引:24
作者
Kavanagh, BD
Secomb, TW [1 ]
Hsu, R
Lin, PS
Venitz, J
Dewhirst, MW
机构
[1] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Radiat Oncol, Denver, CO USA
[3] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA USA
[4] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA USA
[5] Duke Univ, Dept Radiat Oncol, Durham, NC USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2002年 / 53卷 / 01期
关键词
hemoglobin; oxygen affinity; oxygen transport; tumors; hyperoxic gases;
D O I
10.1016/S0360-3016(02)02740-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To develop a theoretical model for oxygen delivery to tumors, and to use the model to simulate the effects of changing the affinity of hemoglobin for oxygen on tumor oxygenation. Methods and Materials: Hemoglobin affinity is expressed in terms of P-50, the partial pressure of oxygen (Po-2) at half saturation. Effects of changing P-50 on arterial Po-2 are predicted using an effective vessel approach to describe diffusive oxygen transport in the lungs, assuming fixed systemic oxygen demand and fixed blood flow rate. The decline in oxygen content of blood as it flows through normal tissue before entering the tumor region is assumed fixed. The hypoxic fraction of the tumor region is predicted using a three-dimensional simulation of diffusion from a network of vessels whose geometry is derived from observations of tumor microvasculature in the rat. Results: In air-breathing rats, predicted hypoxic fraction decreases with moderate increases in P-50, but increases with further increases of P-50, in agreement with previous experimental results. In rats breathing hyperoxic gases, and in humans breathing either normoxic or hyperoxic gases, increased P-50 is predicted to improve tumor oxygenation. Conclusions: The results support the administration of synthetic agents to increase P-50 during radiation treatment of tumors. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 25 条
[1]   ALLOSTERIC MODIFIERS OF HEMOGLOBIN - 2-[4-[[(3,5-DISUBSTITUTED ANILINO)CARBONYL]METHYL]PHENOXY]-2-METHYLPROPIONIC ACID-DERIVATIVES THAT LOWER THE OXYGEN-AFFINITY OF HEMOGLOBIN IN RED-CELL SUSPENSIONS, IN WHOLE-BLOOD, AND INVIVO IN RATS [J].
ABRAHAM, DJ ;
WIREKO, FC ;
RANDAD, RS ;
POYART, C ;
KISTER, J ;
BOHN, B ;
LIARD, JF ;
KUNERT, MP .
BIOCHEMISTRY, 1992, 31 (38) :9141-9149
[2]  
DEWHIRST MW, 1994, CANCER RES, V54, P3333
[3]   PERIVASCULAR OXYGEN-TENSIONS IN A TRANSPLANTABLE MAMMARY-TUMOR GROWING IN A DORSAL FLAP WINDOW CHAMBER [J].
DEWHIRST, MW ;
ONG, ET ;
KLITZMAN, B ;
SECOMB, TW ;
VINUYA, RZ ;
DODGE, R ;
BRIZEL, D ;
GROSS, JF .
RADIATION RESEARCH, 1992, 130 (02) :171-182
[4]  
Dewhirst MW, 1996, BRIT J CANCER, V74, pS241
[5]   The effects of hyperoxic and hypercarbic gases on tumour blood flow [J].
Dunn, TJ ;
Braun, RD ;
Rhemus, WE ;
Rosner, GL ;
Secomb, TW ;
Tozer, GM ;
Chaplin, DJ ;
Dewhirst, MW .
BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) :117-126
[6]   Effects of FIO2 on hemodynamic responses and O2 transport during RSR13-induced reduction in P50 [J].
Eichelbrönner, O ;
Sielenkämper, A ;
D'Almeida, M ;
Ellis, CG ;
Sibbald, WJ ;
Chin-Yee, IH .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (01) :H290-H298
[7]   CHLOROPHENOXY ACETIC-ACID DERIVATIVES AS HEMOGLOBIN MODIFIERS AND TUMOR RADIOSENSITIZERS [J].
HIRST, DG ;
WOOD, PJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (05) :1183-1186
[8]   RELATIONSHIP BETWEEN RADIOBIOLOGICAL HYPOXIA AND DIRECT ESTIMATES OF TUMOR OXYGENATION IN A MOUSE-TUMOR MODEL [J].
HORSMAN, MR ;
KHALIL, AA ;
NORDSMARK, M ;
GRAU, C ;
OVERGAARD, J .
RADIOTHERAPY AND ONCOLOGY, 1993, 28 (01) :69-71
[9]   A Phase I study of RSR13, a radiation-enhancing hemoglobin modifier: Tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics [J].
Kavanagh, BD ;
Khandelwal, SR ;
Schmidt-Ullrich, RK ;
Roberts, JD ;
Shaw, EG ;
Pearlman, AD ;
Venitz, J ;
Dusenbery, KE ;
Abraham, DJ ;
Gerber, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (04) :1133-1139
[10]  
Khandelwal S. R., 1996, RADIAT ONCOL INVEST, V4, P51